Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Investors might want to bet on Phreesia (PHR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Fintel reports that on October 8, 2025, Keybanc maintained coverage of Phreesia (NYSE:PHR) with a Overweight recommendation. Analyst Price Forecast Suggests 49.85% Upside As of September 30, 2025, the ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Phreesia, Inc. (NYSE:PHR) ranks among the list of stocks with improving ...

Phreesia, Inc. PHR has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because PHR is now in overbought territory with an RSI value of 70.05.

Analysts fell to the sidelines weighing in on Phreesia (PHR – Research Report) and SAGE Therapeutics (SAGE – Research Report) with neutral ratings, indicating that the experts are neither bullish nor ...

Phreesia's strong performance in 2Q24, with revenue surpassing expectations and better-than-expected EBITDA, demonstrates growth potential and a path to profitability. Management's commitment to ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...